Uc - ulcerative colitis
Clinical trials for Uc - ulcerative colitis explained in plain language.
Never miss a new study
Get alerted when new Uc - ulcerative colitis trials appear
Sign up with your email to follow new studies for Uc - ulcerative colitis, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug LYNC-101 enters first human trials for ulcerative colitis
Disease control By invitation onlyThis early-stage trial tests the safety of an experimental drug called LYNC-101 in 50 healthy adults. The drug is given by IV infusion, either as a single dose or multiple doses every 3 weeks. The goal is to see if it is safe and how the body processes it, before testing it in pe…
Matched conditions: UC - ULCERATIVE COLITIS
Phase 1 • Sponsor: LyncBio Therapeutics Co., Ltd. • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
New drug D-2570 aims to quiet Flare-Ups in ulcerative colitis
Disease control OngoingThis study tests whether an experimental drug called D-2570 can help people with moderately to severely active ulcerative colitis achieve remission. About 120 adults will receive either D-2570 or a placebo daily for 12 weeks. The main goal is to see if more people on D-2570 reach…
Matched conditions: UC - ULCERATIVE COLITIS
Phase 2 • Sponsor: InventisBio Co., Ltd • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Gut check: 4,000-Person study links diet, genes, and stomach troubles
Knowledge-focused By invitation onlyThis study looks at how diet, genetics, and gut bacteria work together to cause digestive problems like IBS, IBD, and celiac disease. Researchers will follow about 4,000 adults with and without these conditions to find patterns. The goal is to understand why some people get sick …
Matched conditions: UC - ULCERATIVE COLITIS
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:06 UTC